Compare Boston Scientific Corporation (BSX) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Boston Scientific Corporation trades at $43.36 (market cap $66.37B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $27.45. The key difference: ProShares UltraShort Bloomberg Natural Gas ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | KOLD | |
|---|---|---|
Market Cap | $66.37B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $108.14 | $49.39 |
52-Week Low | $42.63 | $13.58 |
Enterprise Value | $75.94B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
KOLD, the ProShares UltraShort Bloomberg Natural Gas ETF, trades at $27.98, up 3.78% on the day. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest overbought conditions. Recent news highlights volatility in natural gas futures driven by weather forecasts and LNG demand, with the ETF positioned as a tactical trading tool amid price swings around $3/MMBtu. The overall technical signal is bullish, but oscillators remain neutral, indicating potential near-term consolidation.
The outlook for KOLD is tied to natural gas price volatility, with opportunities for short-term gains if gas prices decline due to rising supply or milder weather. Key risks include unexpected demand spikes from heat waves or geopolitical events, which could pressure the inverse ETF. Investors should monitor EIA storage reports and weather trends closely, as these are primary catalysts for movement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
